MTND5P20

Across TCGA pan-cancer cohorts, MTND5P20 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MTND5P20’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MTND5P20 RNA is repressed in tumor relative to normal tissue. In most cancer types MTND5P20 is over-expressed in tumor, although a few such as THCA and KIRC show the opposite, repressed pattern.

THCA, BRCA, and KIRC are the cancer types where MTND5P20 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTND5P20 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.237	.007	3	view →
BRCA	Female	All	+0.147	.022	2	view →
KIRC	Male	All	−0.065	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MTND5P20–THCA

Open the THCA breakdown →